Daniel Echeverría-Esnal
-
- Antibiotic Use and Resistance 14
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 8
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies 6
- SARS-CoV-2 and COVID-19 Research 5
- Antimicrobial Resistance in Staphylococcus 5
- Geriatrics and Gerontology top 10%
-
- Antibiotics Pharmacokinetics and Efficacy 14
-
- Patient Satisfaction in Healthcare 6
-
- Urinary Tract Infections Management 4
- Co-authors
- Santiago GrauJuan Pablo HorcajadaOlivia FerrándezClara Martín‐OntiyueloM.P. Gracia-ArnillasXavier DuránLuisa SorlíSílvia Gómez-Zorrilla
- Journals
- SHILAP Revista de lepidopterología (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)Transplantation (1 paper)
In The Last Decade
Daniel Echeverría-Esnal
39 papers receiving 584 citations
Peers
Comparison fields: 5 of 94
- Applied Microbiology and Biotechnology 201
- Molecular Medicine 85
- Infectious Diseases 288
- Critical Care and Intensive Care Medicine 42
- Geriatrics and Gerontology 27
Countries citing papers authored by Daniel Echeverría-Esnal
This map shows the geographic impact of Daniel Echeverría-Esnal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Echeverría-Esnal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Echeverría-Esnal more than expected).
Fields of papers citing papers by Daniel Echeverría-Esnal
This network shows the impact of papers produced by Daniel Echeverría-Esnal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Echeverría-Esnal. The network helps show where Daniel Echeverría-Esnal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniel Echeverría-Esnal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 5 | |
| 9 | 2022 | 5 | |
| 10 | 2021 | 0 | |
| 11 | 2021 | 17 | |
| 12 | 2021 | 70 | |
| 13 | 2021 | 12 | |
| 14 | 2021 | 10 | |
| 15 | 2021 | 5 | |
| 16 | 2021 | 32 | |
| 17 | 2020 | 6 | |
| 18 | 2019 | 10 | |
| 19 | 2018 | 14 | |
| 20 | 2015 | 4 |
About Daniel Echeverría-Esnal
Daniel Echeverría-Esnal is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Pharmacology, having authored 41 papers that have together received 592 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (14 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (8 papers), Patient Satisfaction in Healthcare (6 papers), COVID-19 Clinical Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Urinary Tract Infections Management (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (201 citations), Molecular Medicine (85 citations) and Infectious Diseases (288 citations). Daniel Echeverría-Esnal has collaborated with scholars based in Spain, Czechia and Australia. Frequent co-authors include Santiago Grau, Juan Pablo Horcajada, Olivia Ferrández, Clara Martín‐Ontiyuelo, M.P. Gracia-Arnillas, Xavier Durán, Luisa Sorlí, Sílvia Gómez-Zorrilla, Francisco Álvarez-Lerma and Sònia Luque. Their work appears in journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.